| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.624 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.563 | |
| intra s dna damage checkpoint | GO:0031573 | 4 | 0.473 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.395 | |
| cell cycle arrest | GO:0007050 | 37 | 0.384 | Human |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.370 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.367 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.314 | Human |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.305 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.295 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.280 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.279 | |
| dna metabolic process | GO:0006259 | 303 | 0.253 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.225 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.222 | Human |
| response to ionizing radiation | GO:0010212 | 42 | 0.218 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.218 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.215 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.204 | |
| signal transduction involved in dna integrity checkpoint | GO:0072401 | 3 | 0.202 | |
| b cell activation | GO:0042113 | 161 | 0.201 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.199 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.195 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.183 | |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.175 | |
| protein catabolic process | GO:0030163 | 221 | 0.169 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.168 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.167 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.159 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.158 | Fly |
| protein localization to organelle | GO:0033365 | 185 | 0.156 | |
| positive regulation of cell proliferation involved in heart valve morphogenesis | GO:0003251 | 1 | 0.152 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.152 | Fly |
| cytokine production | GO:0001816 | 319 | 0.151 | |
| regulation of transforming growth factor beta2 production | GO:0032909 | 2 | 0.148 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.145 | Fly |
| leukocyte differentiation | GO:0002521 | 342 | 0.140 | |
| regionalization | GO:0003002 | 337 | 0.139 | Fly |
| positive regulation of extrinsic apoptotic signaling pathway via death domain receptors | GO:1902043 | 13 | 0.138 | |
| response to growth factor | GO:0070848 | 198 | 0.134 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.130 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.130 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.127 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.127 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.127 | |
| regulation of system process | GO:0044057 | 200 | 0.125 | |
| mitotic g1 dna damage checkpoint | GO:0031571 | 4 | 0.121 | |
| cation transport | GO:0006812 | 399 | 0.120 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.119 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.119 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.115 | Human |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.115 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.115 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.114 | |
| negative regulation of dna replication | GO:0008156 | 4 | 0.110 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.109 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.108 | |
| regulation of g1 s transition of mitotic cell cycle | GO:2000045 | 35 | 0.108 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.107 | |
| germ cell development | GO:0007281 | 185 | 0.105 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.103 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.103 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.102 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.102 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.101 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.101 | Human Worm |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.101 | |
| fibroblast migration | GO:0010761 | 21 | 0.100 | |
| regulation of cyclin dependent protein serine threonine kinase activity | GO:0000079 | 16 | 0.098 | |
| regulation of smad protein import into nucleus | GO:0060390 | 3 | 0.098 | |
| regulation of transforming growth factor beta receptor signaling pathway | GO:0017015 | 43 | 0.097 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.096 | |
| b cell proliferation | GO:0042100 | 53 | 0.096 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.095 | Fly |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.095 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.095 | |
| postreplication repair | GO:0006301 | 5 | 0.094 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.094 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.094 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.092 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.091 | |
| signal transduction involved in mitotic dna damage checkpoint | GO:1902402 | 3 | 0.090 | |
| regulation of autophagy | GO:0010506 | 30 | 0.088 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.087 | |
| regulation of cell cycle g1 s phase transition | GO:1902806 | 35 | 0.087 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.086 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.086 | |
| regulation of microtubule polymerization or depolymerization | GO:0031110 | 20 | 0.084 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.083 | |
| inflammatory response | GO:0006954 | 244 | 0.083 | |
| amine metabolic process | GO:0009308 | 45 | 0.081 | |
| organelle fission | GO:0048285 | 170 | 0.081 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.081 | |
| b cell differentiation | GO:0030183 | 78 | 0.081 | |
| protein autophosphorylation | GO:0046777 | 61 | 0.081 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.081 | |
| regulation of protein binding | GO:0043393 | 60 | 0.080 | |
| negative regulation of transferase activity | GO:0051348 | 85 | 0.079 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.078 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.078 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.078 | |
| nuclear division | GO:0000280 | 158 | 0.077 | |
| extrinsic apoptotic signaling pathway via death domain receptors | GO:0008625 | 34 | 0.077 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.077 | |
| positive regulation of apoptotic signaling pathway | GO:2001235 | 95 | 0.076 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.075 | |
| meiosis i | GO:0007127 | 60 | 0.075 | |
| blood coagulation | GO:0007596 | 76 | 0.074 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.074 | |
| cell proliferation involved in heart valve morphogenesis | GO:0003249 | 1 | 0.074 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.073 | |
| regulation of cell proliferation involved in heart valve morphogenesis | GO:0003250 | 1 | 0.073 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.072 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.072 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.072 | |
| negative regulation of cell growth | GO:0030308 | 44 | 0.071 | |
| negative regulation of transforming growth factor beta receptor signaling pathway | GO:0030512 | 26 | 0.070 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.070 | Fly |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.070 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.070 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.069 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.068 | |
| regulation of cell substrate adhesion | GO:0010810 | 73 | 0.068 | |
| regulation of binding | GO:0051098 | 111 | 0.068 | |
| negative regulation of protein depolymerization | GO:1901880 | 21 | 0.067 | |
| microtubule based process | GO:0007017 | 236 | 0.067 | Fly |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.067 | |
| gene silencing | GO:0016458 | 38 | 0.067 | |
| response to uv b | GO:0010224 | 5 | 0.066 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.066 | |
| cell fate commitment | GO:0045165 | 210 | 0.066 | Worm Fly |
| myeloid cell differentiation | GO:0030099 | 233 | 0.066 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.066 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.066 | Human |
| lymphocyte proliferation | GO:0046651 | 164 | 0.065 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.065 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.065 | |
| regulation of transcription by galactose | GO:0000409 | 1 | 0.065 | |
| response to x ray | GO:0010165 | 11 | 0.065 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.064 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.064 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.063 | |
| nephrogenic mesenchyme morphogenesis | GO:0072134 | 2 | 0.063 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.062 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.061 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.061 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.061 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.060 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.060 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.060 | |
| signal transduction involved in dna damage checkpoint | GO:0072422 | 3 | 0.060 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.059 | |
| protein maturation | GO:0051604 | 176 | 0.059 | |
| kidney mesenchyme morphogenesis | GO:0072131 | 4 | 0.059 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.059 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.059 | |
| male gamete generation | GO:0048232 | 285 | 0.058 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.058 | |
| protein processing | GO:0016485 | 163 | 0.056 | |
| carbon catabolite activation of transcription | GO:0045991 | 4 | 0.056 | |
| somatic hypermutation of immunoglobulin genes | GO:0016446 | 7 | 0.056 | |
| chromatin organization | GO:0006325 | 206 | 0.056 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.056 | |
| female gamete generation | GO:0007292 | 74 | 0.056 | Fly |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.056 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.055 | |
| actin filament bundle assembly | GO:0051017 | 40 | 0.055 | |
| regulation of cell activation | GO:0050865 | 289 | 0.055 | |
| response to oxidative stress | GO:0006979 | 123 | 0.055 | Worm |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.054 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.054 | |
| brainstem development | GO:0003360 | 3 | 0.054 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.054 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.053 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.053 | |
| immune effector process | GO:0002252 | 321 | 0.053 | |
| negative regulation of osteoblast proliferation | GO:0033689 | 4 | 0.053 | |
| transdifferentiation | GO:0060290 | 1 | 0.052 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.052 | |
| regulation of canonical wnt signaling pathway | GO:0060828 | 82 | 0.051 | |
| canonical wnt signaling pathway involved in negative regulation of apoptotic process | GO:0044336 | 4 | 0.051 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.051 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.051 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.051 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.051 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.051 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.051 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.050 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.050 | |
| circulatory system process | GO:0003013 | 197 | 0.050 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.050 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.050 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.049 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.049 | |
| sensory perception | GO:0007600 | 245 | 0.049 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.048 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.048 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.048 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.048 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.048 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.047 | |
| cell cycle g1 s phase transition | GO:0044843 | 57 | 0.047 | |
| dna catabolic process endonucleolytic | GO:0000737 | 15 | 0.047 | |
| dna damage response signal transduction by p53 class mediator resulting in cell cycle arrest | GO:0006977 | 3 | 0.047 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.046 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.046 | |
| negative regulation of transcription involved in g1 s transition of mitotic cell cycle | GO:0071930 | 1 | 0.046 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.046 | |
| positive regulation of cell cycle phase transition | GO:1901989 | 17 | 0.045 | |
| negative regulation of organ growth | GO:0046621 | 17 | 0.045 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.045 | |
| meiotic cell cycle process | GO:1903046 | 77 | 0.045 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.045 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.045 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.045 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.045 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.044 | |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.044 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.044 | |
| glucose metabolic process | GO:0006006 | 92 | 0.044 | |
| negative regulation of t cell apoptotic process | GO:0070233 | 18 | 0.043 | |
| associative learning | GO:0008306 | 61 | 0.043 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.043 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.043 | |
| t cell activation | GO:0042110 | 289 | 0.042 | |
| macroautophagy | GO:0016236 | 21 | 0.042 | |
| negative regulation of synaptic vesicle exocytosis | GO:2000301 | 3 | 0.042 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.042 | |
| negative regulation of cyclin dependent protein serine threonine kinase activity | GO:0045736 | 9 | 0.042 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.042 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.042 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.042 | Fly |
| dna damage checkpoint | GO:0000077 | 26 | 0.042 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.042 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.042 | |
| chemotaxis | GO:0006935 | 247 | 0.042 | |
| transforming growth factor beta2 production | GO:0032906 | 2 | 0.042 | |
| positive regulation of cell substrate adhesion | GO:0010811 | 47 | 0.041 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.041 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.041 | |
| maintenance of location | GO:0051235 | 89 | 0.041 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.040 | |
| cell adhesion | GO:0007155 | 329 | 0.040 | Fly |
| multicellular organism growth | GO:0035264 | 161 | 0.040 | |
| dna replication | GO:0006260 | 52 | 0.040 | |
| negative regulation of mapk cascade | GO:0043409 | 65 | 0.040 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.040 | |
| connective tissue development | GO:0061448 | 179 | 0.040 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.040 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.039 | |
| cellular senescence | GO:0090398 | 11 | 0.039 | |
| negative regulation of g1 s transition of mitotic cell cycle | GO:2000134 | 18 | 0.039 | |
| dna repair | GO:0006281 | 107 | 0.039 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.039 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.039 | |
| exocytosis | GO:0006887 | 121 | 0.038 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.038 | Worm |
| regulation of peptidyl threonine phosphorylation | GO:0010799 | 12 | 0.038 | |
| striated muscle cell development | GO:0055002 | 125 | 0.038 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.038 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.038 | |
| nucleotide excision repair | GO:0006289 | 13 | 0.038 | |
| regulation of meiotic cell cycle | GO:0051445 | 34 | 0.038 | |
| positive regulation of peptidase activity | GO:0010952 | 49 | 0.038 | |
| cell cycle switching mitotic to meiotic cell cycle | GO:0051728 | 1 | 0.038 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.038 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.038 | |
| atp catabolic process | GO:0006200 | 55 | 0.037 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.037 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.037 | |
| dendrite development | GO:0016358 | 115 | 0.037 | |
| smad protein complex assembly | GO:0007183 | 1 | 0.037 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.037 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.037 | |
| hexose metabolic process | GO:0019318 | 98 | 0.037 | |
| cell growth | GO:0016049 | 130 | 0.037 | |
| skeletal system development | GO:0001501 | 356 | 0.037 | |
| somatic diversification of immune receptors via somatic mutation | GO:0002566 | 8 | 0.036 | |
| cellular response to antibiotic | GO:0071236 | 4 | 0.036 | |
| negative regulation of cellular catabolic process | GO:0031330 | 47 | 0.036 | |
| axonogenesis | GO:0007409 | 274 | 0.036 | |
| positive regulation of ubiquitin protein transferase activity | GO:0051443 | 4 | 0.036 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.036 | |
| nuclear import | GO:0051170 | 95 | 0.036 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.036 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.036 | |
| proteasomal protein catabolic process | GO:0010498 | 98 | 0.035 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.035 | Fly |
| stem cell differentiation | GO:0048863 | 268 | 0.035 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.035 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.035 | |
| regulation of phospholipase c activity | GO:1900274 | 3 | 0.035 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.035 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.035 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.035 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.035 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.034 | Worm |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.034 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.034 | |
| atp metabolic process | GO:0046034 | 75 | 0.034 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.034 | |
| intracellular protein transport | GO:0006886 | 204 | 0.034 | |
| cerebellum development | GO:0021549 | 77 | 0.034 | |
| negative regulation of fatty acid metabolic process | GO:0045922 | 10 | 0.034 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.034 | |
| modulation by virus of host morphology or physiology | GO:0019048 | 3 | 0.034 | |
| protein ubiquitination | GO:0016567 | 171 | 0.034 | |
| cellular homeostasis | GO:0019725 | 240 | 0.034 | |
| regulation of cell size | GO:0008361 | 72 | 0.034 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.034 | |
| positive regulation of mitotic cell cycle phase transition | GO:1901992 | 17 | 0.034 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.033 | |
| negative regulation of bmp signaling pathway | GO:0030514 | 35 | 0.033 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.033 | |
| oxidative phosphorylation | GO:0006119 | 14 | 0.033 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.033 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.033 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.033 | |
| blastocyst development | GO:0001824 | 80 | 0.033 | |
| intracellular signal transduction involved in g1 dna damage checkpoint | GO:1902400 | 3 | 0.033 | |
| spermatogenesis | GO:0007283 | 284 | 0.033 | |
| regulation of cohesin localization to chromatin | GO:0071922 | 1 | 0.032 | |
| dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator | GO:0006978 | 2 | 0.032 | |
| negative regulation of lymphocyte proliferation | GO:0050672 | 45 | 0.032 | |
| zymogen activation | GO:0031638 | 41 | 0.032 | |
| genetic imprinting | GO:0071514 | 27 | 0.032 | |
| positive regulation of rap gtpase activity | GO:0032854 | 3 | 0.032 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.032 | |
| attachment of spindle microtubules to kinetochore | GO:0008608 | 4 | 0.032 | |
| fatty acid transmembrane transport | GO:1902001 | 1 | 0.032 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.032 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.032 | |
| cerebellar cortex development | GO:0021695 | 48 | 0.032 | |
| positive regulation of mitotic cell cycle | GO:0045931 | 41 | 0.032 | |
| regulation of cell motility | GO:2000145 | 236 | 0.032 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.032 | |
| response to light stimulus | GO:0009416 | 135 | 0.032 | |
| muscle tissue development | GO:0060537 | 308 | 0.032 | |
| response to uv | GO:0009411 | 44 | 0.031 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.031 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.031 | |
| mitotic sister chromatid separation | GO:0051306 | 9 | 0.031 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.031 | |
| regulation of leukocyte apoptotic process | GO:2000106 | 56 | 0.031 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.031 | |
| coagulation | GO:0050817 | 78 | 0.031 | |
| negative regulation of synaptic vesicle transport | GO:1902804 | 3 | 0.031 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.031 | |
| positive t cell selection | GO:0043368 | 23 | 0.030 | |
| response to radiation | GO:0009314 | 165 | 0.030 | |
| nuclear transport | GO:0051169 | 139 | 0.030 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.030 | |
| cellular response to lipid | GO:0071396 | 145 | 0.030 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.030 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.030 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.030 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.030 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.030 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.030 | |
| cell aging | GO:0007569 | 35 | 0.030 | |
| mapk cascade | GO:0000165 | 281 | 0.030 | Fly |
| positive regulation of cell death | GO:0010942 | 224 | 0.030 | Fly |
| striated muscle tissue development | GO:0014706 | 293 | 0.030 | |
| spleen development | GO:0048536 | 39 | 0.030 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.029 | |
| negative regulation of peptidyl threonine phosphorylation | GO:0010801 | 6 | 0.029 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.029 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.029 | |
| t cell differentiation | GO:0030217 | 174 | 0.029 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.029 | |
| cellular response to nitric oxide | GO:0071732 | 4 | 0.029 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.029 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.029 | |
| negative regulation of endothelial cell migration | GO:0010596 | 4 | 0.029 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.029 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.029 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 19 | 0.029 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.029 | |
| mitotic cell cycle arrest | GO:0071850 | 4 | 0.029 | |
| dna catabolic process | GO:0006308 | 19 | 0.029 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.028 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.028 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.028 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.028 | |
| zygotic determination of anterior posterior axis embryo | GO:0007354 | 3 | 0.028 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.028 | |
| somite development | GO:0061053 | 81 | 0.028 | |
| hemostasis | GO:0007599 | 78 | 0.028 | |
| metencephalon development | GO:0022037 | 89 | 0.028 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.028 | |
| cellular response to epidermal growth factor stimulus | GO:0071364 | 4 | 0.028 | |
| regulation of protein modification by small protein conjugation or removal | GO:1903320 | 57 | 0.028 | |
| male gonad development | GO:0008584 | 88 | 0.028 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.028 | |
| osteoblast fate commitment | GO:0002051 | 4 | 0.028 | |
| wound healing | GO:0042060 | 157 | 0.028 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.027 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.027 | |
| cell cycle switching | GO:0060184 | 1 | 0.027 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.027 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.027 | |
| endothelial cell activation | GO:0042118 | 1 | 0.027 | |
| positive regulation of macroautophagy | GO:0016239 | 3 | 0.027 | |
| negative regulation of dna recombination | GO:0045910 | 13 | 0.027 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.027 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.027 | |
| double strand break repair | GO:0006302 | 48 | 0.027 | |
| calcium ion transport into cytosol | GO:0060402 | 48 | 0.027 | |
| regulation of ion transport | GO:0043269 | 215 | 0.027 | |
| oocyte axis specification | GO:0007309 | 2 | 0.027 | Fly |
| cellular protein complex assembly | GO:0043623 | 116 | 0.027 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.027 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.026 | |
| positive regulation of mammary gland involution | GO:1903521 | 4 | 0.026 | |
| metanephric mesenchyme morphogenesis | GO:0072133 | 4 | 0.026 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.026 | |
| regulation of cell growth | GO:0001558 | 91 | 0.026 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.026 | |
| negative regulation of protein catabolic process | GO:0042177 | 36 | 0.026 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.026 | |
| positive regulation of cell projection organization | GO:0031346 | 95 | 0.026 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.026 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.026 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.026 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.026 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.026 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.026 | |
| forebrain development | GO:0030900 | 302 | 0.026 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.026 | |
| regulation of cellular protein catabolic process | GO:1903362 | 61 | 0.026 | |
| pole plasm assembly | GO:0007315 | 2 | 0.026 | Fly |
| negative regulation of leukocyte proliferation | GO:0070664 | 46 | 0.025 | |
| organ growth | GO:0035265 | 117 | 0.025 | |
| cardiac chamber development | GO:0003205 | 108 | 0.025 | |
| regulation of fatty acid biosynthetic process | GO:0042304 | 12 | 0.025 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.025 | |
| epithelium migration | GO:0090132 | 63 | 0.025 | |
| negative regulation of cellular protein catabolic process | GO:1903363 | 22 | 0.025 | |
| endothelial cell migration | GO:0043542 | 44 | 0.025 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.025 | |
| oxidation reduction process | GO:0055114 | 342 | 0.025 | |
| response to inorganic substance | GO:0010035 | 96 | 0.025 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.025 | |
| regulation of proteasomal protein catabolic process | GO:0061136 | 46 | 0.025 | |
| protein depolymerization | GO:0051261 | 34 | 0.025 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.025 | |
| metaphase anaphase transition of mitotic cell cycle | GO:0007091 | 9 | 0.025 | |
| dna endoreduplication | GO:0042023 | 4 | 0.024 | |
| embryonic placenta development | GO:0001892 | 98 | 0.024 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.024 | |
| dna recombination | GO:0006310 | 92 | 0.024 | |
| male courtship behavior | GO:0008049 | 2 | 0.024 | |
| regulation of cell migration | GO:0030334 | 219 | 0.024 | |
| negative regulation of cellular response to growth factor stimulus | GO:0090288 | 46 | 0.024 | |
| neural tube closure | GO:0001843 | 90 | 0.024 | |
| skeletal muscle fiber development | GO:0048741 | 58 | 0.024 | |
| female sex differentiation | GO:0046660 | 84 | 0.024 | |
| somatic diversification of immunoglobulins involved in immune response | GO:0002208 | 36 | 0.024 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.024 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.024 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.024 | |
| mitotic spindle assembly checkpoint | GO:0007094 | 7 | 0.024 | |
| protein targeting | GO:0006605 | 143 | 0.024 | |
| protein localization to chromatin | GO:0071168 | 3 | 0.023 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.023 | |
| cardiac endothelial cell differentiation | GO:0003348 | 4 | 0.023 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.023 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.023 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.023 | |
| regulation of wound healing | GO:0061041 | 40 | 0.023 | |
| germ line stem cell division | GO:0042078 | 2 | 0.023 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.023 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.023 | |
| germline cell cycle switching mitotic to meiotic cell cycle | GO:0051729 | 1 | 0.023 | |
| digestive system development | GO:0055123 | 200 | 0.023 | Zebrafish |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.023 | |
| positive regulation of phospholipase c activity | GO:0010863 | 2 | 0.023 | |
| negative regulation of mammary gland epithelial cell proliferation | GO:0033600 | 3 | 0.023 | |
| ovarian follicle development | GO:0001541 | 40 | 0.023 | |
| regulation of hippo signaling | GO:0035330 | 1 | 0.023 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.023 | |
| kidney development | GO:0001822 | 213 | 0.023 | |
| regulation of secretion | GO:0051046 | 274 | 0.022 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.022 | |
| cell proliferation involved in heart valve development | GO:2000793 | 2 | 0.022 | |
